Eden et al., 2011 - Google Patents
The urokinase receptor interactomeEden et al., 2011
View PDF- Document ID
- 11561070202688317976
- Author
- Eden G
- Archinti M
- Furlan F
- Murphy R
- Degryse B
- Publication year
- Publication venue
- Current pharmaceutical design
External Links
Snippet
The urokinase receptor (uPAR) was originally identified as the membrane receptor of the serine protease urokinase (uPA), thereby implicated in the plasminogen activation cascade and regulation of pericellular proteolysis. Later on, vitronectin was showed to be another …
- 102000003990 Urokinase-type plasminogen activator 0 title abstract description 161
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Eden et al. | The urokinase receptor interactome | |
| Ragno | The urokinase receptor: a ligand or a receptor? Story of a sociable molecule | |
| Mazar et al. | The urokinase plasminogen activator system in cancer: implications for tumor angiogenesis and metastasis | |
| Blasi et al. | uPAR: a versatile signalling orchestrator | |
| Nicholl et al. | Plasminogen activator system and vascular disease | |
| López‐Alemany et al. | Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against α‐Enolase | |
| Romer et al. | The urokinase receptor as a potential target in cancer therapy | |
| Deng et al. | Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? | |
| Huang | What have snakes taught us about integrins? | |
| Vincenza Carriero et al. | The urokinase-type plasminogen activator and the generation of inhibitors of urokinase activity and signaling | |
| US20110027285A1 (en) | Methods and agents modulating upa/upar activity | |
| Ghebrehiwet et al. | Soluble gC1qR is an autocrine signal that induces B1R expression on endothelial cells | |
| Del Rosso et al. | The urokinase-type plasminogen activator system and inflammatory joint diseases | |
| Ghebrehiwet et al. | Targeting gC1qR domains for therapy against infection and inflammation | |
| Stephan et al. | Tissue factor pathway inhibitor is an inhibitor of factor VII‐activating protease | |
| Goldfarb | Proteolytic enzymes in tumor invasion and degradation of host extracellular matrices | |
| Derian et al. | Thrombin regulation of cell function through protease-activated receptors: implications for therapeutic intervention | |
| Engelholm et al. | The urokinase receptor associated protein (uPARAP/endo180): a novel internalization receptor connected to the plasminogen activation system | |
| Preissner et al. | The dual role of the urokinase receptor system in pericellular proteolysis and cell adhesion: implications for cardiovascular function | |
| Mohanam et al. | Biological significance of the expression of urokinase-type plasminogen activator receptors (uPARs) in brain tumors | |
| JP2000506854A (en) | Targeted therapeutic or diagnostic agents and methods of making and using same | |
| AU2011223563A1 (en) | Modulation of intracellular signaling | |
| Tucker et al. | Lipoprotein receptor–related protein 1 regulates collagen 1 expression, proteolysis, and migration in human pleural mesothelial cells | |
| Chen et al. | Thrombomodulin functions as a plasminogen receptor to modulate angiogenesis | |
| US20030138429A1 (en) | Compositions and methods for inhibiting metastasis |